| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
Latest News
Despite Shkreli Drama, Retrophin Looks Interesting Now
One biotech portfolio manager thinks Retrophin, the biotech company once run by indicted hedge fund manager Martin Shkreli, could be a promising investment.
January 2014 Options Now Available For ELN
Investors in Elan Corp plc saw new options begin trading today, for the January 2014 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ELN options chain for the new January 2014 contracts and identified the following put contract of particular interest.
Elan Announces Shareholder Approval Of Its Acquisition By Perrigo Company
The shareholders of Elan Corporation, plc (NYSE:ELN) ("Elan") today overwhelmingly approved the acquisition of Elan by Perrigo Company (“Perrigo”) (NYSE, TASE: PRGO) at two special meetings of Elan ...
Celtic Tiger Tries to Roar Again
The situation in Ireland is improving. Here's a way you can invest in that.
Viking Global Sells Apple, Boeing; Buys Yahoo, Facebook
Andreas Halvorsen’s Viking Global teamed up with other tiger cubs in buyingaBaidu Inc (NASDAQ:BIDU). Viking initiated a new position in the Chinese language search engine with 2.67 million shar...
Elan Reports Third Quarter 2013 Financial Results
Elan Corporation, plc (NYSE:ELN) today reported its third quarter and first nine months 2013 financial results.
Elan Announces Webcast Of Third Quarter 2013 Financial Results
Elan Corporation, plc (NYSE:ELN) announced today that it will host a conference call on Thursday, October 24, 2013 at 8:30 a.
Elan Announces Dates Of Shareholder Meetings In Connection With Scheme Of Arrangement
Elan Corporation, plc (NYSE:ELN) today announced that it has scheduled shareholder meetings for Monday, November 18, 2013 in connection with Perrigo Company’s (NYSE, TASE: PRGO) (“Perrigo”) proposed...
Elan Announces Dosing Of First Patient In Phase 2a Trial Of ELND005 (Scyllo-inositol) In Down Syndrome
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome.
Cramer's 6 Stocks in 60 Seconds: PRGO CREE HOG GME ORCL MHK (Update 1)
Cramer remains bullish on Cree and thinks Harley-Davidson will continue riding to profit,
The 5 Dumbest Things on Wall Street This Week: Aug. 2
Gregg Greenberg writes that Zynga loses, fertiilzers stink, Ackman's big mouth proves awkward and more.
Wanted: a few good sponsor deals
: 2013's M&A scene is clearly down, and PE's famed club deals are out.
'Fast Money' Recap: Which Way Will the Market Go?
The trading panel pondered the market's direction in a week of earnings and economic data.
Cramer's 'Mad Money' Recap: Merger Monday Is Back
Mergers are great news for every investor, Cramer said.
U.S. Stocks Retreat as Wariness Grows Amid Summer Slumber
Stocks are falling Monday as investors retreat to the sidelines to await data on U.S. growth and an indication which way the Fed is leaning.
Cramer: 3 Mergers, 3 Wins
But not all are good for stocks overall.
Elan Corporation Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Sale To Perrigo Company
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Elan Corporation, plc (“Elan”) (NYSE:...
With Elan Deal, Perrigo Joins Long List of U.S. Corporate Tax Avoiders
From humble roots in western Michigan, Perrigo is moving to Ireland so it can pay less in U.S. taxes.
The Deal: Elan Agrees on $8.6B Takeover by Perrigo
Elan said it had agreed on an $8.6 billion takeover by pharmaceuticals company Perrigo.
Stock Futures Slide on Cautious Fed, Growth Outlook
U.S. stock futures are pointing to a sluggish open Monday ahead of the Fed's policy announcement on Wednesday.
Merger Monday Doesn't Lift Stocks
A big ad merger between Omnicom and Publicis, plus a drug merger between Perrigo and Elan doesn't help lift stocks ahead of the Fed.
Morning Briefing: 10 Things You Should Know
U.S. stock futures are lower; ad giants Omnicom and Publicis agree to a merger; Perrigo to buy Elan for $8.6 billion; Hertz to report earnings.
Perrigo to Buy Elan for $8.6 Billion
U.S. drugmaker Perrigo agrees to buy Ireland's Elan for $8.6 billion.
Elan Reports Second Quarter And First Half 2013 Financial Results
Elan Corporation, plc (NYSE:ELN) today reported its second quarter and first half 2013 financial results.
SEC Charges SAC Capital's Billionaire Head Steven A. Cohen
The SEC has charged Steven A. Cohen of SAC Capital with failing to supervise its portfolio managers.
FDA Grant Fast Track Designation To ELND005 For The Treatment Of Neuropsychiatric Symptoms In Alzheimer’s Disease
Elan Corporation, plc (NYSE:ELN) announced today that the US Food and Drug Administration (FDA) has granted Fast Track Designation to its development program for ELND005 which was submitted for the treatment of ...
Elan Announces Webcast Of Second Quarter 2013 Financial Results
Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, July 24, 2013 at 8:30 a.
The 5 Dumbest Things on Wall Street This Week: June 21
Men's Wearhouse can't like the way they look; Elan runs a circuitous path of Irish deal making; bombast crashes the Paris Air Show and more.